Things are moving quickly in the mobility sector as the race to develop autonomous vehicle technologies revs up. This week brought a spate of mobility news from GM and Cruise, Ford, BAE, and even the federal government. Read on for details.... Read more »
The praise Heptio co-founder Joe Beda received after the Seattle startup company announced a $25 million funding round “seems a little strange,” he said in a tweet Wednesday, because the “real work” is still ahead.
[Corrected 12:20pm ET; see below.] The national debate over the high cost of healthcare, with prescription drugs at the center, resonates from the chambers of Congress to every American’s pocketbook. And it’s growing fiercer by the day. Last week, the first... Read more »
Startups in Washington, Oregon, and British Columbia can look forward to more regional networking and, perhaps, an increased pool of investment capital under a pair of initiatives announced Tuesday.
The Cascadia Innovation Network, spearheaded by the Canadian Consulate General in Seattle,... Read more »
Leaders from the life sciences and technology industries are coming together for Xconomy’s special event on artificial intelligence in healthcare on Nov. 9 at Cambia Grove in Seattle. Act now to get the best price on tickets for what we expect... Read more »
Amazon lists one requirement in the stunning request for proposals it issued Thursday, which invites cities across North America to compete to host a second corporate headquarters for the tech and commerce giant.
Economic development officials are justifiably salivating at the... Read more »
The summer doldrums are over. Biotech news came at a breakneck pace this week both before and after Labor Day, starting with the surprise resignation of Novartis’s top executive just days after the Swiss company notched an historic FDA approval.
From... Read more »
[Updated 4:26 p.m. See below.] Amazon sent cities across North America into a frenzy Thursday after announcing plans to build a second headquarters outside of Seattle, bringing with it tens of thousands of jobs and billions of dollars in... Read more »
Biotech CEOs Jeremy Levin and Steve Holtzman are continuing their recent push to spur the life sciences industry to speak out against government policies it doesn’t agree with.
Levin, CEO of Ovid Therapeutics (NASDAQ: OVID) and Holtzman, the head of... Read more »